Pub Date : 2025-11-18eCollection Date: 2025-01-01DOI: 10.61622/rbgo/2025rbgo90
Beatriz Villegas-Lara, Oswaldo Sinoe Medina-Gómez
Objective: To estimate age-adjusted mortality rates at the national and state levels, evaluates trends and their spatial distribution during the period 2000-2023 among Mexican women.
Methods: Ecological study conducted from open access data, the age-standardized mortality rate of breast cancer during the period 2000-2023 was calculated. Joinpoint regression models were estimated for breast cancer mortality in Mexico and its states. Spatial analysis was performed using Moran's I statistic.
Results: The age-adjusted mortality rate at the national level during 2000 was 18.99 per 100,000 women, the highest mortality rate occurred in the year 2020. Joinpoint analysis shows a decrease in mortality in the last five years, being greater in urban areas. For 2023, the highest mortality occurred in Sonora and Chihuahua, while Mexico City (-0.71; 95%CI -0.98 to -0.44) was the entity that showed a significant reduction in the mortality rate from breast cancer. The spatial analysis showed a local indicator of spatial association of 0.458 (p<0.05) for 2000 and 0.524 (p<0.05) for 2023 in the northern states of the country.
Conclusion: Public health interventions must be implemented according to the social, economic, and cultural context to reduce mortality from breast cancer.
{"title":"Trends in breast cancer mortality in Mexican women.","authors":"Beatriz Villegas-Lara, Oswaldo Sinoe Medina-Gómez","doi":"10.61622/rbgo/2025rbgo90","DOIUrl":"10.61622/rbgo/2025rbgo90","url":null,"abstract":"<p><strong>Objective: </strong>To estimate age-adjusted mortality rates at the national and state levels, evaluates trends and their spatial distribution during the period 2000-2023 among Mexican women.</p><p><strong>Methods: </strong>Ecological study conducted from open access data, the age-standardized mortality rate of breast cancer during the period 2000-2023 was calculated. Joinpoint regression models were estimated for breast cancer mortality in Mexico and its states. Spatial analysis was performed using Moran's I statistic.</p><p><strong>Results: </strong>The age-adjusted mortality rate at the national level during 2000 was 18.99 per 100,000 women, the highest mortality rate occurred in the year 2020. Joinpoint analysis shows a decrease in mortality in the last five years, being greater in urban areas. For 2023, the highest mortality occurred in Sonora and Chihuahua, while Mexico City (-0.71; 95%CI -0.98 to -0.44) was the entity that showed a significant reduction in the mortality rate from breast cancer. The spatial analysis showed a local indicator of spatial association of 0.458 (p<0.05) for 2000 and 0.524 (p<0.05) for 2023 in the northern states of the country.</p><p><strong>Conclusion: </strong>Public health interventions must be implemented according to the social, economic, and cultural context to reduce mortality from breast cancer.</p>","PeriodicalId":74699,"journal":{"name":"Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","volume":"47 ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12671663/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145673133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-18eCollection Date: 2025-01-01DOI: 10.61622/rbgo/2025rbgo91
Rômulo Felipe Auler, Ramon Henrique Auler, Ana Clara Machado Teixeira, Giovanna Jost Tibolla, Vinícius Pessoa Nunes Vieira, Junior Bolsonelo, Edimárlei Gonsales Valério, Edison Capp
Objective: Advanced maternal age has become more common due to factors such as increased academic preparation for women, labor market participation, delayed family planning, and advances in reproductive medicine. This phenomenon raises questions about the risks and gestational outcomes associated with advanced maternal age (AMA). This study aims to explore the gestational and perinatal outcomes in pregnant women with AMA (> 35 years), comparing them with those of women aged 20 to 34 years.
Methods: The research was conducted as an observational and retrospective analysis, examining data from 2012 to 2022 from the Hospital Production System (SIH/SUS) available on the DATAsus platform, covering all regions of Brazil. Variables analyzed included gestational duration, type of pregnancy (single or multiple), mode of delivery, Robson group, APGAR score at five minutes, birth weight, and occurrence of congenital anomalies.
Results: Pregnant women with AMA showed statistically significant differences in the higher percentage of cesarean sections (63.3% AMA vs 58% non-AMA, p<0.05), higher percentage of low birth weight newborns (12.5% AMA vs 6.7% non-AMA, p<0.05), lower APGAR scores at the fifth minute (OR = 1.08, p<0.001) and a higher prevalence of any congenital anomalies (1.23% AMA vs 0.77% non-AMA, OR =OR = 1.34, p < 0.001). In addition, this group had a higher incidence of premature births (12.99% AMA vs 8.78% non-AMA) and multiple pregnancies (1.39% AMA vs 0.83% non-AMA). Furthermore, in the Robson classification, there was a predominance of older mothers in Group 5 (previous cesarean section) and in the groups with nulliparity.
Conclusion: Pregnant women with AMA face higher gestational and perinatal risks, such as preterm births and an increased need for cesarean sections. These findings underscore the importance of public policies and personalized management strategies to improve maternal and neonatal outcomes for older pregnant women.
目的:由于妇女学业准备增加、劳动力市场参与、计划生育推迟以及生殖医学的进步等因素,高龄产妇变得越来越普遍。这种现象提出了与高龄产妇(AMA)相关的风险和妊娠结局的问题。本研究旨在探讨AMA (bb0 ~ 35岁)孕妇的妊娠和围产期结局,并将其与20 ~ 34岁妇女的妊娠和围产期结局进行比较。方法:本研究采用观察性和回顾性分析的方法,对DATAsus平台上的医院生产系统(SIH/SUS) 2012年至2022年的数据进行分析,涵盖巴西所有地区。分析的变量包括妊娠期、妊娠类型(单胎或多胎)、分娩方式、Robson组、5分钟APGAR评分、出生体重和先天性异常的发生。结果:AMA孕妇剖宫产率较高(63.3% AMA vs 58%非AMA)差异有统计学意义。结论:AMA孕妇面临更高的妊娠期和围产期风险,如早产和剖宫产需求增加。这些发现强调了公共政策和个性化管理策略对改善高龄孕妇孕产妇和新生儿结局的重要性。
{"title":"Analysis of the influence of advanced maternal age on gestational and fetal outcomes.","authors":"Rômulo Felipe Auler, Ramon Henrique Auler, Ana Clara Machado Teixeira, Giovanna Jost Tibolla, Vinícius Pessoa Nunes Vieira, Junior Bolsonelo, Edimárlei Gonsales Valério, Edison Capp","doi":"10.61622/rbgo/2025rbgo91","DOIUrl":"10.61622/rbgo/2025rbgo91","url":null,"abstract":"<p><strong>Objective: </strong>Advanced maternal age has become more common due to factors such as increased academic preparation for women, labor market participation, delayed family planning, and advances in reproductive medicine. This phenomenon raises questions about the risks and gestational outcomes associated with advanced maternal age (AMA). This study aims to explore the gestational and perinatal outcomes in pregnant women with AMA (> 35 years), comparing them with those of women aged 20 to 34 years.</p><p><strong>Methods: </strong>The research was conducted as an observational and retrospective analysis, examining data from 2012 to 2022 from the Hospital Production System (SIH/SUS) available on the DATAsus platform, covering all regions of Brazil. Variables analyzed included gestational duration, type of pregnancy (single or multiple), mode of delivery, Robson group, APGAR score at five minutes, birth weight, and occurrence of congenital anomalies.</p><p><strong>Results: </strong>Pregnant women with AMA showed statistically significant differences in the higher percentage of cesarean sections (63.3% AMA vs 58% non-AMA, p<0.05), higher percentage of low birth weight newborns (12.5% AMA vs 6.7% non-AMA, p<0.05), lower APGAR scores at the fifth minute (OR = 1.08, p<0.001) and a higher prevalence of any congenital anomalies (1.23% AMA vs 0.77% non-AMA, OR =OR = 1.34, p < 0.001). In addition, this group had a higher incidence of premature births (12.99% AMA vs 8.78% non-AMA) and multiple pregnancies (1.39% AMA vs 0.83% non-AMA). Furthermore, in the Robson classification, there was a predominance of older mothers in Group 5 (previous cesarean section) and in the groups with nulliparity.</p><p><strong>Conclusion: </strong>Pregnant women with AMA face higher gestational and perinatal risks, such as preterm births and an increased need for cesarean sections. These findings underscore the importance of public policies and personalized management strategies to improve maternal and neonatal outcomes for older pregnant women.</p>","PeriodicalId":74699,"journal":{"name":"Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","volume":"47 ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12671664/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145673177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-18eCollection Date: 2025-01-01DOI: 10.61622/rbgo/2025rbgo86
Rumeysa Çınar, Özlem Kayacık Günday, Ahmet Kahraman, Mehmet Yılmazer
Objective: This study aims to explore the combined role of ANGPTL3, 4, 8, omentin-1, leptin, TNF-α, and IL-6 molecules known for their roles in fat metabolism, obesity, and inflammation, yet whose connection to PCOS is still debated in the development of PCOS.
Methods: A prospective cross-sectional study involving PCOS patients (n=30) and BMI-matched controls (n=30) was conducted. Levels of ANGPTL3, 4, 8, omentin-1, leptin, TNF-α, and IL-6 were measured in peripheral venous blood samples.
Results: When dividing both the PCOS and control groups into six BMI-based subgroups normal weight (20-24.9 kg/m2), slightly overweight (25-29.9 kg/m2), and obese (30-39.9 kg/m2) there were significant differences in levels of ANGPTL3 and 8, omentin-1, leptin, IL-6, and TNF-α (p<0.05). Comparison between the entire PCOS and control groups showed that CRP levels were significantly higher in the PCOS group (p<0.0001), while omentin-1 levels were significantly lower (p=0.022). Regression analysis, including ANGPTL3, 4, 8, IL-6, and TNF-α alongside CRP and omentin-1, indicated a significant model for PCOS (Nagelkerke R2=0.698, p<0.0001, PPV=80%, NPV=90%). In ROC analysis, the AUC for CRP and omentin-1 were significant (p<0.05; AUC=0.800-0.328).
Conclusion: This study suggests a continuous interaction among ANGPTL, omentin-1, leptin, and cytokines in the etiopathogenesis of PCOS.
{"title":"The combination of circulating levels of ANGPTL, omentin-1, leptin and cytokines is associated with polycystic ovary syndrome in different BMI groups.","authors":"Rumeysa Çınar, Özlem Kayacık Günday, Ahmet Kahraman, Mehmet Yılmazer","doi":"10.61622/rbgo/2025rbgo86","DOIUrl":"10.61622/rbgo/2025rbgo86","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to explore the combined role of ANGPTL3, 4, 8, omentin-1, leptin, TNF-α, and IL-6 molecules known for their roles in fat metabolism, obesity, and inflammation, yet whose connection to PCOS is still debated in the development of PCOS.</p><p><strong>Methods: </strong>A prospective cross-sectional study involving PCOS patients (n=30) and BMI-matched controls (n=30) was conducted. Levels of ANGPTL3, 4, 8, omentin-1, leptin, TNF-α, and IL-6 were measured in peripheral venous blood samples.</p><p><strong>Results: </strong>When dividing both the PCOS and control groups into six BMI-based subgroups normal weight (20-24.9 kg/m<sup>2</sup>), slightly overweight (25-29.9 kg/m<sup>2</sup>), and obese (30-39.9 kg/m<sup>2</sup>) there were significant differences in levels of ANGPTL3 and 8, omentin-1, leptin, IL-6, and TNF-α (p<0.05). Comparison between the entire PCOS and control groups showed that CRP levels were significantly higher in the PCOS group (p<0.0001), while omentin-1 levels were significantly lower (p=0.022). Regression analysis, including ANGPTL3, 4, 8, IL-6, and TNF-α alongside CRP and omentin-1, indicated a significant model for PCOS (Nagelkerke R<sup>2</sup>=0.698, p<0.0001, PPV=80%, NPV=90%). In ROC analysis, the AUC for CRP and omentin-1 were significant (p<0.05; AUC=0.800-0.328).</p><p><strong>Conclusion: </strong>This study suggests a continuous interaction among ANGPTL, omentin-1, leptin, and cytokines in the etiopathogenesis of PCOS.</p>","PeriodicalId":74699,"journal":{"name":"Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","volume":"47 ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12671682/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145673144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-11eCollection Date: 2025-01-01DOI: 10.61622/rbgo/2025FPS9
Rosires Pereira de Andrade, Fernanda Garanhani de Castro Surita, Aline Veras Morais Brilhante, Robinson Dias de Medeiros, Cristião Fernando Rosas, Helena Borges Martins da Silva Paro, Marla Niag Dos Santos Rocha, Olimpio Barbosa de Moraes, Sara de Pinho Cunha Paiva, Stenia Dos Santos Lins, Marcia Sacramento Cunha Machado, Rivaldo Mendes de Albuquerque, Jose Paulo de Siqueira Guida, Zelia Maria Campos, Marli Camara Abelha
Prompt care for victims of sexual violence is essential in the implementation of measures to prevent pregnancy resulting from violence and sexually transmitted infections, and to assess and monitor serological follow-up and gather evidence for possible criminal proceedings. In the absence of a referral service, any health service should take the appropriate initial measures and refer the victim to the referral service (if there is one) as quickly as possible. Referral services for immediate care for victims of sexual violence allow victims to be followed up for a longer period of time. However, acute care should be provided by any health unit to avoid care delays. There is no need for any legal complaint or registration of a police report for providing healthcare to victims of sexual violence. However, victims should be informed about their right to report the assault at any time, so an appropriate legal and police investigation can be carried out. It is important to address this topic during medical care. All services providing care to victims of sexual violence must be open and receiving victims continuously, without the need for other health units or a police authority. Obstetrician/gynecologists are often the professionals responsible for caring for victims of sexual violence and must be familiar with the initial care protocols for these patients.
{"title":"Immediate care for victims of sexual violence: Number 9 - 2025.","authors":"Rosires Pereira de Andrade, Fernanda Garanhani de Castro Surita, Aline Veras Morais Brilhante, Robinson Dias de Medeiros, Cristião Fernando Rosas, Helena Borges Martins da Silva Paro, Marla Niag Dos Santos Rocha, Olimpio Barbosa de Moraes, Sara de Pinho Cunha Paiva, Stenia Dos Santos Lins, Marcia Sacramento Cunha Machado, Rivaldo Mendes de Albuquerque, Jose Paulo de Siqueira Guida, Zelia Maria Campos, Marli Camara Abelha","doi":"10.61622/rbgo/2025FPS9","DOIUrl":"10.61622/rbgo/2025FPS9","url":null,"abstract":"<p><p>Prompt care for victims of sexual violence is essential in the implementation of measures to prevent pregnancy resulting from violence and sexually transmitted infections, and to assess and monitor serological follow-up and gather evidence for possible criminal proceedings. In the absence of a referral service, any health service should take the appropriate initial measures and refer the victim to the referral service (if there is one) as quickly as possible. Referral services for immediate care for victims of sexual violence allow victims to be followed up for a longer period of time. However, acute care should be provided by any health unit to avoid care delays. There is no need for any legal complaint or registration of a police report for providing healthcare to victims of sexual violence. However, victims should be informed about their right to report the assault at any time, so an appropriate legal and police investigation can be carried out. It is important to address this topic during medical care. All services providing care to victims of sexual violence must be open and receiving victims continuously, without the need for other health units or a police authority. Obstetrician/gynecologists are often the professionals responsible for caring for victims of sexual violence and must be familiar with the initial care protocols for these patients.</p>","PeriodicalId":74699,"journal":{"name":"Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","volume":"47 ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12671677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145672980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-29eCollection Date: 2025-01-01DOI: 10.61622/rbgo/2025FPS8
Omero Benedicto Poli, Julio Cesar Rosa E Silva, Carlos Alberto Petta, Carlos Augusto Pires Costa Lino, Eduardo Schor, Helizabet Salomão Abdalla Ayroza Ribeiro, João Nogueira, João Sabino Lahorgue da Cunha, Marcia Cristina França, Márcia Mendonça Carneiro, Marco Aurélio Pinho de Oliveira, Marcos Tcherniakovsky, Maurício Simões Abrão, Raquel Papandreus Dib, Ricardo de Almeida Quintairos, Sergio Podgaec, Sidney Pearce
•Chronic pelvic pain is a common and complex condition that significantly affects women's quality of life. •Neuropathic pain and nociplastic pain are important components in the pain picture of these patients and should be considered in clinical treatment. •Oral neuromodulators, antidepressants and anticonvulsants for the control of neuropathic and nociplastic pain should be present in the therapeutic arsenal of the gynecologist who treats patients with chronic pelvic pain. •Pregabalin is the medication with the best pharmacokinetic profile; nortriptyline has the best adverse effects profile; duloxetine is the most widely used and has the lowest risks; and venlafaxine should be used as a second-line inhibitor. •Although the drug classes can be combined to reduce the total doses and minimize side effects, maximizing the analgesic effect, monotherapies are recommended as the first line to avoid polypharmacy.
{"title":"Use of oral neuromodulators in chronic pelvic painNumber 8 - 2025.","authors":"Omero Benedicto Poli, Julio Cesar Rosa E Silva, Carlos Alberto Petta, Carlos Augusto Pires Costa Lino, Eduardo Schor, Helizabet Salomão Abdalla Ayroza Ribeiro, João Nogueira, João Sabino Lahorgue da Cunha, Marcia Cristina França, Márcia Mendonça Carneiro, Marco Aurélio Pinho de Oliveira, Marcos Tcherniakovsky, Maurício Simões Abrão, Raquel Papandreus Dib, Ricardo de Almeida Quintairos, Sergio Podgaec, Sidney Pearce","doi":"10.61622/rbgo/2025FPS8","DOIUrl":"10.61622/rbgo/2025FPS8","url":null,"abstract":"<p><p>•Chronic pelvic pain is a common and complex condition that significantly affects women's quality of life. •Neuropathic pain and nociplastic pain are important components in the pain picture of these patients and should be considered in clinical treatment. •Oral neuromodulators, antidepressants and anticonvulsants for the control of neuropathic and nociplastic pain should be present in the therapeutic arsenal of the gynecologist who treats patients with chronic pelvic pain. •Pregabalin is the medication with the best pharmacokinetic profile; nortriptyline has the best adverse effects profile; duloxetine is the most widely used and has the lowest risks; and venlafaxine should be used as a second-line inhibitor. •Although the drug classes can be combined to reduce the total doses and minimize side effects, maximizing the analgesic effect, monotherapies are recommended as the first line to avoid polypharmacy.</p>","PeriodicalId":74699,"journal":{"name":"Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","volume":"47 ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12671683/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145673102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Women may experience cognitive, emotional, and physical changes during the menstrual cycle, which can impact their physical and athletic performance. This study aimed to investigate whether Brazilian female swimmers in the senior category, i.e., over 18 years of age, federated with the Brazilian Confederation of Aquatic Sports (CBDA), use hormonal contraceptives (HCs) and assess the impacts on their health, athletic performance, and overall well-being.
Methods: This is a cross-sectional descriptive observational study conducted via an online questionnaire based on the Google Forms® platform, sent via WhatsApp® and email to the participants. Questions were asked about age, use of contraceptive methods, observed changes in performance, among others. A total of 136 senior athletes participated in the study. Inclusion criteria were senior female athletes using hormonal contraceptive methods. Athletes who were not in the senior category and/or did not use hormonal contraceptive methods were excluded from the research.
Results: A total of 136 senior athletes responded to the questionnaire. Of this total, 108 reported using hormonal contraceptive methods and were therefore included in the study. The results indicate that the majority of participants use oral contraceptives, with 61 (57%) using this method. Regarding the reason for using hormonal contraceptives, 88 (82.4%) use the method to control the menstrual cycle, in addition to alleviating menstrual symptoms, 63 (59.2%); 62 (57.9%) reported improvement in mood patterns, and 69 (64.55%) stated that they experience benefits from using the method.
Conclusion: It is concluded that the use of hormonal contraceptives presents benefits related to the professional careers of athletes. Besides improving their training performance, HCs also help alleviate menstrual symptoms and control the menstrual cycle and flow.
{"title":"The use of hormonal contraceptives in high performance Brazilian female swimmers: a cross-sectional study.","authors":"Ana Carla Carvalho, Natani Gaio, Patrícia Cristiane Müller, Simone Carla Benincá","doi":"10.61622/rbgo/2025rbgo82","DOIUrl":"10.61622/rbgo/2025rbgo82","url":null,"abstract":"<p><strong>Objective: </strong>Women may experience cognitive, emotional, and physical changes during the menstrual cycle, which can impact their physical and athletic performance. This study aimed to investigate whether Brazilian female swimmers in the senior category, i.e., over 18 years of age, federated with the Brazilian Confederation of Aquatic Sports (CBDA), use hormonal contraceptives (HCs) and assess the impacts on their health, athletic performance, and overall well-being.</p><p><strong>Methods: </strong>This is a cross-sectional descriptive observational study conducted via an online questionnaire based on the Google Forms® platform, sent via WhatsApp® and email to the participants. Questions were asked about age, use of contraceptive methods, observed changes in performance, among others. A total of 136 senior athletes participated in the study. Inclusion criteria were senior female athletes using hormonal contraceptive methods. Athletes who were not in the senior category and/or did not use hormonal contraceptive methods were excluded from the research.</p><p><strong>Results: </strong>A total of 136 senior athletes responded to the questionnaire. Of this total, 108 reported using hormonal contraceptive methods and were therefore included in the study. The results indicate that the majority of participants use oral contraceptives, with 61 (57%) using this method. Regarding the reason for using hormonal contraceptives, 88 (82.4%) use the method to control the menstrual cycle, in addition to alleviating menstrual symptoms, 63 (59.2%); 62 (57.9%) reported improvement in mood patterns, and 69 (64.55%) stated that they experience benefits from using the method.</p><p><strong>Conclusion: </strong>It is concluded that the use of hormonal contraceptives presents benefits related to the professional careers of athletes. Besides improving their training performance, HCs also help alleviate menstrual symptoms and control the menstrual cycle and flow.</p>","PeriodicalId":74699,"journal":{"name":"Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","volume":"47 ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711235/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-21eCollection Date: 2025-01-01DOI: 10.61622/rbgo/2025rbgo63
Michelly Siqueira-Souza, Carolina Chicharo Vivas, Jéssica Couto Dos Anjos, Gabrielle Barbosa Anelli Morau, Júlia Kefalás Troncon, Lucianna Fonseca Barreto, Carolina Gennari Verruma, Rosana Maria Dos Reis
An 8-year-old girl presented with vaginal bleeding without puberty signs. During investigation at 10 years old, the patient presented with advanced bone age, prepubertal hormone levels and internal genitalia. Hysteroscopy and vaginoscopy at 10 years and 10 months of age revealed endometrial proliferation despite infantile genitalia. Histopathology showed positive receptors for estrogen and progesterone. This is the first report of endometrial estrogen and progesterone receptor activity in this context. Despite normal serum estradiol, the findings suggest a local action of estrogen. Follow-up until 11 years of age showed progressive development of secondary sexual characteristics. This case report emphasizes the need to consider isolated vaginal bleeding, without the development of secondary sexual characteristics, as a result of endometrial hypersensitivity to low estrogen levels during pubertal development, which may alter the chronology of pubertal development in girls.
{"title":"Endometrial estrogen and progesterone receptor activity in unusual chronology of pubertal development: a case report.","authors":"Michelly Siqueira-Souza, Carolina Chicharo Vivas, Jéssica Couto Dos Anjos, Gabrielle Barbosa Anelli Morau, Júlia Kefalás Troncon, Lucianna Fonseca Barreto, Carolina Gennari Verruma, Rosana Maria Dos Reis","doi":"10.61622/rbgo/2025rbgo63","DOIUrl":"10.61622/rbgo/2025rbgo63","url":null,"abstract":"<p><p>An 8-year-old girl presented with vaginal bleeding without puberty signs. During investigation at 10 years old, the patient presented with advanced bone age, prepubertal hormone levels and internal genitalia. Hysteroscopy and vaginoscopy at 10 years and 10 months of age revealed endometrial proliferation despite infantile genitalia. Histopathology showed positive receptors for estrogen and progesterone. This is the first report of endometrial estrogen and progesterone receptor activity in this context. Despite normal serum estradiol, the findings suggest a local action of estrogen. Follow-up until 11 years of age showed progressive development of secondary sexual characteristics. This case report emphasizes the need to consider isolated vaginal bleeding, without the development of secondary sexual characteristics, as a result of endometrial hypersensitivity to low estrogen levels during pubertal development, which may alter the chronology of pubertal development in girls.</p>","PeriodicalId":74699,"journal":{"name":"Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","volume":"47 ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12671666/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145672913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-21eCollection Date: 2025-01-01DOI: 10.61622/rbgo/2025rbgo66
Fernando Maia Peixoto, Ana Heloisa Nascimento Beserra, Maria Cristina Pessoa Dos Santos
Objective: This study sought to analyze the profile of fetuses, newborns and pregnant women with alloimmunization (anti-RhD) referred to and treated over the twenty years since the launch of the Rio de Janeiro State.
Methods: An observational, retrospective, descriptive study was conducted, with data obtained by analyzing the medical records of 481 mothers and their newborns. The study cohort consisted of pregnancies affected by RhD alloimmunization who delivered between March 2004 and March 2024 in Rio de Janeiro.
Results: The absolute number of cases declined over the study period. Only 5.2% of the cohort began prenatal care in the first trimester of pregnancy and more than half (51.6%) of women arrived at the referral center in the third trimester. 40% of the women had prior severe HDFN. During this period, 422 intrauterine transfusions were performed on 71 fetuses, an average of 5.9 transfusions per patient. Infant mortality; was low, with 4% stillborn or evolving to neonatal mortality.
Conclusion: The trend observed over the last 20 years is a reduction in the absolute number of HDFN cases which is perhaps more related to reproductive issues, particularly the sharp reduction in parity in our state, rather than to the implementation of alloimmunization prophylaxis.
{"title":"20 years experience of RhD alloimmunization at a state referral center in Rio de Janeiro: a study of 481 cases.","authors":"Fernando Maia Peixoto, Ana Heloisa Nascimento Beserra, Maria Cristina Pessoa Dos Santos","doi":"10.61622/rbgo/2025rbgo66","DOIUrl":"10.61622/rbgo/2025rbgo66","url":null,"abstract":"<p><strong>Objective: </strong>This study sought to analyze the profile of fetuses, newborns and pregnant women with alloimmunization (anti-RhD) referred to and treated over the twenty years since the launch of the Rio de Janeiro State.</p><p><strong>Methods: </strong>An observational, retrospective, descriptive study was conducted, with data obtained by analyzing the medical records of 481 mothers and their newborns. The study cohort consisted of pregnancies affected by RhD alloimmunization who delivered between March 2004 and March 2024 in Rio de Janeiro.</p><p><strong>Results: </strong>The absolute number of cases declined over the study period. Only 5.2% of the cohort began prenatal care in the first trimester of pregnancy and more than half (51.6%) of women arrived at the referral center in the third trimester. 40% of the women had prior severe HDFN. During this period, 422 intrauterine transfusions were performed on 71 fetuses, an average of 5.9 transfusions per patient. Infant mortality; was low, with 4% stillborn or evolving to neonatal mortality.</p><p><strong>Conclusion: </strong>The trend observed over the last 20 years is a reduction in the absolute number of HDFN cases which is perhaps more related to reproductive issues, particularly the sharp reduction in parity in our state, rather than to the implementation of alloimmunization prophylaxis.</p>","PeriodicalId":74699,"journal":{"name":"Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","volume":"47 ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12671657/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145673168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-21eCollection Date: 2025-01-01DOI: 10.61622/rbgo/2025rbgo81
Ingrid Schwach, Gustavo Yano Callado, Sandra Rejane Silva Herbst, Daniel Dante Cardeal, Milton Hikaro Toita, Giselle Darahem Tedesco, Flavia Canhassi Corigliano, Juliana Dos Passos Pires, Carolina Leite Drummond, Edward Araujo
Objective: To describe preliminary results of open fetal myelomeningocele surgeries performed at a tertiary public hospital in São Paulo, Brazil, analyzing epidemiological aspects as well as maternal and fetal perioperative complications.
Methods: This retrospective cohort study included 25 pregnant women whose fetuses were diagnosed with myelomeningocele and underwent open intrauterine surgery between February 2019 and October 2023. Maternal demographic data, surgical outcomes, and neonatal variables were collected from medical records. Statistical analyses included Chi-squared test, Fisher's exact test, Mann-Whitney U test, and Pearson's correlation coefficient (r).
Results: The mean gestational age (GA) at surgery was 25.7 ± 1.2 weeks, and the mean GA at delivery was 34.3 ± 2.0 weeks. Preterm birth was the most common complication (40%), followed by premature rupture of ovular membranes (32%). Two stillbirths occurred (8%) at 31 and 33 weeks of gestation. Median Apgar scores at 1 and 5 minutes were 8 and 9, respectively. Low birth weight (<2,500 g) was observed in 44% of neonates. Neonatal hospitalization was significantly longer in cases of preterm birth (p = 0.044), and intensive care unit stay was longer in deliveries before 34 weeks (p = 0.044). No correlation was found between GA at intrauterine surgery and GA at delivery (r = 0.252, p = 0.22).
Conclusion: Fetal myelomeningocele surgery was successfully performed in a tertiary public hospital. However, preterm birth remains a major concern, as consistently reported in the literature. Nevertheless, the results confirm that intrauterine repair of myelomeningocele is indeed feasible in the public healthcare setting.
{"title":"Fetal surgery for myelomeningocele: initial results of a tertiary public hospital.","authors":"Ingrid Schwach, Gustavo Yano Callado, Sandra Rejane Silva Herbst, Daniel Dante Cardeal, Milton Hikaro Toita, Giselle Darahem Tedesco, Flavia Canhassi Corigliano, Juliana Dos Passos Pires, Carolina Leite Drummond, Edward Araujo","doi":"10.61622/rbgo/2025rbgo81","DOIUrl":"10.61622/rbgo/2025rbgo81","url":null,"abstract":"<p><strong>Objective: </strong>To describe preliminary results of open fetal myelomeningocele surgeries performed at a tertiary public hospital in São Paulo, Brazil, analyzing epidemiological aspects as well as maternal and fetal perioperative complications.</p><p><strong>Methods: </strong>This retrospective cohort study included 25 pregnant women whose fetuses were diagnosed with myelomeningocele and underwent open intrauterine surgery between February 2019 and October 2023. Maternal demographic data, surgical outcomes, and neonatal variables were collected from medical records. Statistical analyses included Chi-squared test, Fisher's exact test, Mann-Whitney U test, and Pearson's correlation coefficient (r).</p><p><strong>Results: </strong>The mean gestational age (GA) at surgery was 25.7 ± 1.2 weeks, and the mean GA at delivery was 34.3 ± 2.0 weeks. Preterm birth was the most common complication (40%), followed by premature rupture of ovular membranes (32%). Two stillbirths occurred (8%) at 31 and 33 weeks of gestation. Median Apgar scores at 1 and 5 minutes were 8 and 9, respectively. Low birth weight (<2,500 g) was observed in 44% of neonates. Neonatal hospitalization was significantly longer in cases of preterm birth (p = 0.044), and intensive care unit stay was longer in deliveries before 34 weeks (p = 0.044). No correlation was found between GA at intrauterine surgery and GA at delivery (r = 0.252, p = 0.22).</p><p><strong>Conclusion: </strong>Fetal myelomeningocele surgery was successfully performed in a tertiary public hospital. However, preterm birth remains a major concern, as consistently reported in the literature. Nevertheless, the results confirm that intrauterine repair of myelomeningocele is indeed feasible in the public healthcare setting.</p>","PeriodicalId":74699,"journal":{"name":"Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","volume":"47 ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711234/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-21eCollection Date: 2025-01-01DOI: 10.61622/rbgo/2025rbgo67
Rakhi Gaur, Kalpana Thakur, Navjot Kaur, Rajan Kumar, Vipin Patidar, Priyanka Rai
Objective: When spontaneous vaginal delivery is not feasible, Instrument-assisted vaginal delivery (IVD) is utilized, which often involves the use of vacuum extractors (VE) and obstetric forceps. This study intent to evaluate the risks and benefits associated with utilizing obstetric forceps vs vacuum extractors for IVD, focusing on maternal and neonatal outcomes.
Methods: Following PRISMA guidelines, a full literature search was done in PubMed, Embase, and Google Scholar until April 2024. The review examined randomized controlled trials (RCTs) that compared forceps and vacuum extractors. Two writers extracted the data and assessed its quality separately, with a third resolving any inconsistencies. The statistical study was conducted using R software, with a random-effects model used to quantify risk differences and evaluate heterogeneity.
Results: Seven RCTs, totalling 2,299 individuals, were included. A meta-analysis revealed that forceps significantly increased the incidence of perineal tears (Risk difference = 0.08, 95% CI 0.02-0.13) and vaginal injuries (Risk Difference = 0.12, 95% CI 0.05-0.19). Vacuum extractors were associated with an increased risk of infant cephalohematoma (Risk Difference = -0.06, 95% CI -0.08, -0.04). There was no significant difference in maternal anaesthesia required or failure to accomplish vaginal delivery with the intended instrument.
Conclusion: Obstetric forceps are more likely to cause maternal perineal tears and vaginal injuries, whereas vacuum extractors increase the likelihood of neonatal cephalohematoma. Both methods have comparable anaesthetic needs and success rates for vaginal birth. The clinical scenario ought to guide the choice of instruments, with an emphasis on risk minimization through proper training.PROSPERO: CRD42024577839.
目的:当自然阴道分娩不可行时,采用器械辅助阴道分娩(IVD),这通常涉及使用真空抽吸器(VE)和产科钳。本研究旨在评估使用产科钳与真空抽吸器进行IVD的风险和益处,重点关注孕产妇和新生儿的结局。方法:遵循PRISMA指南,在PubMed, Embase和谷歌Scholar中进行完整的文献检索,直到2024年4月。该综述检查了比较钳和真空抽拔器的随机对照试验(rct)。两位作者分别提取数据并评估其质量,第三位作者解决任何不一致之处。统计学研究采用R软件进行,采用随机效应模型量化风险差异,评估异质性。结果:纳入7项随机对照试验,共2299人。一项荟萃分析显示,镊子显著增加了会阴撕裂(风险差异= 0.08,95% CI 0.02-0.13)和阴道损伤(风险差异= 0.12,95% CI 0.05-0.19)的发生率。真空抽吸器与婴儿脑血肿风险增加相关(风险差异= -0.06,95% CI = -0.08, -0.04)。在产妇麻醉需要或失败完成阴道分娩与预期的仪器没有显著差异。结论:产科钳更易引起产妇会阴撕裂和阴道损伤,而真空抽吸器更易引起新生儿脑血肿。两种方法的麻醉需求和阴道分娩的成功率相当。临床情况应该指导器械的选择,重点是通过适当的培训将风险降到最低。普洛斯彼罗:CRD42024577839。
{"title":"Efficacy of obstetrics forceps and vacuum extractor to assist during vaginal delivery: systematic review and meta-analysis.","authors":"Rakhi Gaur, Kalpana Thakur, Navjot Kaur, Rajan Kumar, Vipin Patidar, Priyanka Rai","doi":"10.61622/rbgo/2025rbgo67","DOIUrl":"10.61622/rbgo/2025rbgo67","url":null,"abstract":"<p><strong>Objective: </strong>When spontaneous vaginal delivery is not feasible, Instrument-assisted vaginal delivery (IVD) is utilized, which often involves the use of vacuum extractors (VE) and obstetric forceps. This study intent to evaluate the risks and benefits associated with utilizing obstetric forceps vs vacuum extractors for IVD, focusing on maternal and neonatal outcomes.</p><p><strong>Methods: </strong>Following PRISMA guidelines, a full literature search was done in PubMed, Embase, and Google Scholar until April 2024. The review examined randomized controlled trials (RCTs) that compared forceps and vacuum extractors. Two writers extracted the data and assessed its quality separately, with a third resolving any inconsistencies. The statistical study was conducted using R software, with a random-effects model used to quantify risk differences and evaluate heterogeneity.</p><p><strong>Results: </strong>Seven RCTs, totalling 2,299 individuals, were included. A meta-analysis revealed that forceps significantly increased the incidence of perineal tears (Risk difference = 0.08, 95% CI 0.02-0.13) and vaginal injuries (Risk Difference = 0.12, 95% CI 0.05-0.19). Vacuum extractors were associated with an increased risk of infant cephalohematoma (Risk Difference = -0.06, 95% CI -0.08, -0.04). There was no significant difference in maternal anaesthesia required or failure to accomplish vaginal delivery with the intended instrument.</p><p><strong>Conclusion: </strong>Obstetric forceps are more likely to cause maternal perineal tears and vaginal injuries, whereas vacuum extractors increase the likelihood of neonatal cephalohematoma. Both methods have comparable anaesthetic needs and success rates for vaginal birth. The clinical scenario ought to guide the choice of instruments, with an emphasis on risk minimization through proper training.PROSPERO: CRD42024577839.</p>","PeriodicalId":74699,"journal":{"name":"Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","volume":"47 ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12671670/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145672892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}